A Knowledge-Based Risk Advisor Model for Chronic Complications of Diabetes by Sangi, Mohsen et al.
Association for Information Systems
AIS Electronic Library (AISeL)
PACIS 2010 Proceedings Pacific Asia Conference on Information Systems(PACIS)
2010
A Knowledge-Based Risk Advisor Model for
Chronic Complications of Diabetes
Mohsen Sangi
University of Wollongong, ms819@uow.edu.au
Khin Than Win
University of Wollongong, win@uow.edu.au
John Fulcher
University of Wollongong, john@uow.edu.au
Follow this and additional works at: http://aisel.aisnet.org/pacis2010
This material is brought to you by the Pacific Asia Conference on Information Systems (PACIS) at AIS Electronic Library (AISeL). It has been
accepted for inclusion in PACIS 2010 Proceedings by an authorized administrator of AIS Electronic Library (AISeL). For more information, please
contact elibrary@aisnet.org.
Recommended Citation
Sangi, Mohsen; Win, Khin Than; and Fulcher, John, "A Knowledge-Based Risk Advisor Model for Chronic Complications of Diabetes"
(2010). PACIS 2010 Proceedings. 104.
http://aisel.aisnet.org/pacis2010/104
A KNOWLEDGE-BASED RISK ADVISOR MODEL FOR 
CHRONIC COMPLICATIONS OF DIABETES  
Mohsen Sangi, School of Information Systems and Technology, Faculty of Informatics, 
University of Wollongong, Australia, ms819@uow.edu.au 
Khin Than Win, School of Information Systems and Technology, Faculty of Informatics, 
University of Wollongong, Australia, win@uow.edu.au 
John Fulcher, School of Computer Science and Software Engineering, Faculty of Informatics, 
University of Wollongong, Australia, john@uow.edu.au 
Abstract 
Diabetes as an unprecedented epidemic is spreading all around the world. While one in every seven 
healthcare dollars in USA is spent on diabetes, 60% of direct costs and almost 80-90% of indirect 
costs of that are related to diabetic complications. 
The ultimate aim of this study is to develop a rule-based model for advising the risk of chronic 
diabetic complications. An extensive literature review has been carried out to gather actual 
knowledge about diabetic complications and their related predisposing factors. NVivo8 is used to 
organize and categorize the acquired knowledge. A rule-based decision support model is constructed 
from the obtained knowledge. CLIPS is used to represent and implement the rules and build a 
knowledge based decision support system.  
Keywords: Computer assisted decision making, Diabetes-related complications, Rule-based decision 





Diabetes has been well studied, and many of the complications can be prevented. Since it is a multi-
factorial disease, regulated by multiple genes and different environmental factors, which do not follow 
any simple model of inheritance, using information technology and in particular the application of 
decision support systems could be of the most important methods of reducing the heavy burden of this 
disease on the society (Celler et al. 2003). 
Decision support systems (DSS) will assist clinicians in maximizing quality of healthcare and patients 
to understand more of their health. A decision model of diabetes will involve understanding the 
epidemiology of diabetes, diabetes pathophysiology, using of diabetes data meta-analysis, diabetes 
metadata classification and rules and the development of a reasoning engine.  
There is a long history of DSS including different broad-based systems in the medical domain. several 
decision support systems are available in more specific domains of medicine. However, no such 
decision support system exists for the diabetes domain. 
In this study, a decision support model is used to build a rule-based system to assist physicians in 
evidence based medicine. The developed model in the system is able to represent up to date literature 
and individualized patient data for patients tailored decision making.  
2 METHODS 
Available knowledge about diabetes and its complications were gathered from peer reviewed 
publications on clinical trials, meta-analysis, the Cochrane review from Medline, Cinahl, federated 
database searches and diabetes management guidelines published from 1995 to 2009. Keywords were 
integrated with appropriate combinations of:  
• Diabetes or chronic disease and (Prevention or Management) 
• Indicator or Indices and (Diabetes complications or Disease management) 
• Morbidity or Prevalence and (Diabetes or Diabetes complications) 
• Secondary prevention and (Diabetes or Medical/Health informatics) 
• Medical/Health informatics and (Diabetes or Chronic disease) 
• Data mining or Knowledge discovery or Data retrieve and (Diabetes or Diabetes complications) 
• Predictor or Predictive tool or Predictive system and (Diabetes or disease management) 
• Decision support/Expert/Knowledge based system and (Diabetes or disease management) 
• Care reminder system and (Diabetes or Decision support system or Medical/Health informatics) 
• Reasoning engine and (Diabetes or Chronic disease management) 
• Electronic medical record or Electronic disease registry or Electronic patient record and (Diabetes 
or Prevention or Decision support system/Expert system/Knowledge based system) 
Afterwards, having scanned the abstracts of nearly 980 primitive results, about 220 most likely related 
subjects have been chosen and subsequently ranked by 4 criteria in 2 different aspects of study: 
“Diabetes in general OR its related complications” and “DSS in general OR its related technical 
aspects”. The inclusion criteria are shown in Figure 1.  
 




The results from this review work were coded in Nvivo8 to discover associations and themes among 
the diabetes predisposing factors and its complications. A knowledge base including rules was 
developed in this phase of study. The rules in the knowledge base were fed into CLIPS (C Language 
integrated production system) to develop the reasoning part of a decision model for the secondary 
prevention of diabetes. CLIPS has been chosen in this study because of its simplicity, speed and 
capability to work with certainty factors and fuzzy concepts. 
3 RESULTS 
Diabetic chronic complications are mostly produced based on the destructive consequences of chronic 
blood glucose elevation on the internal blood vessels covering cells (endothelial cells). Depending on 
the size of involved vessels, it can be divided into two categories: microvascular disease, due to 
damage to small blood vessels (in the vision system (diabetic retinopathy), neural system (diabetic 
neuropathy), and renal system (diabetic nephropathy) and macrovascular disease, due to damage to 
the arteries (cardiovascular diseases mainly confined to coronary artery diseases heading to 
myocardial infarction, stroke and peripheral vascular diseases). There are some other kinds of 
complications mostly because of combinations of these two. 
The predisposing factors related to diabetes complications are divided into diabetic related factors 
(containing diabetic control by investigating HbA1c (Haemoglobin A1c), duration of disease and type 
of diabetes); behavioural elements (smoking, alcohol consuming, etc.); using medications; patient’s 
individual factors (age, sex, etc.) and having other contemporary diseases or conditions, particularly 
other diabetic microvascular problems. 
Associations linking these two (predisposing factors vs. chronic complications) are extracted from the 
related literatures by applying in Nvivo8 (a qualitative data analysis computer software package 
produced by QSR International). 
3.1 A Knowledge-based model for complications 
The analysis work through Nvivo8 was conducted to identify several themes. At the starting point, an 
inclusive list of diabetes complications and their correlated predisposing factors were derived from the 
existing text books of endocrinology and other reviewed articles, respectively. Both diabetes chronic 
complications and diabetes predisposing factors have been classified hierarchically by 27 and 45 
nodes, in that order. The two are connected by nearly 126 relationships, categorized in three different 
types, namely ‘is a cause for’, ‘prevent from or decrease’ and ‘are the same’. All these nodes and 
relationships are supported by more than 280 paragraphs (facts) of 40 different sources (Table 1).  
Since it is impossible to paraphrase all details in here, the relationships between blood sugar (HbA1c) 
and blood pressure (BP) control as two of the most important predisposing factors and all 
interconnected diabetes chronic complications are illustrated in Figures 2 and Table 2. 
The quality of blood glucose control (for a 3-month period of time) can be deliberated by HbA1c. 
Having a good history of HbA1c level does prevent or decrease the risk of around 10 nodes in the 
diabetes chronic complications tree. On the contrary, mismanaging of that is a cause for the higher 
prevalence of 12 problems; meanwhile, there are 6 common complications between these two groups, 
which can be worse or better related to quality of blood glucose management. These relations 
dispersal are 7 for ‘prevent or decrease’ and 12 ‘is a cause for’ with 3 intersections in the case of 
patient blood pressure control; that is even more complicated here in view of the fact that some 
diabetes complications can affect the blood pressure level while those are sometimes impressed with 
hypertension by themselves, as well. 
With the intention of further exemplifying, Figure 3 illustrates the relationships between HbA1c and 
blood pressure control as two predisposing factors and diabetes nephropathy (including its component 
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Figure2. Relationships between diabetes control (HbA1c) and diabetes complications 
 
Author/Name of 
study Type of study 
Supported relationships 
based on Table 3 
William’s 
CHAPTER 32 Textbook 
(31I), (31J), (31D), (31H), 
(31C) 
(31I), (31J), (31D), (31H), 
(31R), (31A) UKPDS 38 Randomised controlled trial, n=1148, duration: 8.5 years 
(31I), (31J), (31D), (31H), 
(31C), (31M) Dorsey R R Systemic review 
(31D), (31,3), (31,13), 
(31,1) Klein et al. Population-based study, n=765, duration: 10 years 
Bhuripanyo et al. Cross-sectional study, n=2060 (31I), (31J), (31A), (31C) 
Al-Futaisi et al. Cross sectional  study, n=261 (31,6) 
Klein et al. Population-based study, n=996 (31I), (31J) 
Krolewski et al. Randomised controlled trial, n=89, duration: 15 years (31D) 
Kostraba et al. Cross-sectional study, n=657 (31I), (31J) 
Fujisawa et al. Cross-sectional study, n=294 (31I), (31J) 
Mogensen et al.  Population-based study, n=44, duration: 7 years (31D) 
Perkins et al. Population-based study, n=386, duration: 6 years (31,6) 
Hovind et al. Prospective cohort study, n=286, duration: 18 years (31,6) 
Mogensen et al. Population-based study, n=6, duration: 6 years (31D) 
Gaede et al. Randomised controlled trial, n=160, duration: 7.8 years (31N) 
Parving  Systemic review (31D) 
Table 2. Supporting sources of relationships between BP control and diabetes complications 
different kinds of defined relationships are recognized in this figure: 9 ‘is a cause for’, 2 ‘prevent from 
or decrease’ and one ‘are the same’. While both HbA1c and blood pressure control qualifications can 
cause and prevent diabetic nephropathy in patients, at the same time, HbA1c can directly affect on 
patient blood pressure. Furthermore, diabetic nephropathy can cause hypertension in the patient by 
itself. Based on the coded references in Nvivo8, 76 facts through the 19 related sources have been 
linked to these relationships.  




Figure 3. Relationships between HbA1c, blood pressure control and nephropathy 
Around one third of diabetic patients develop persistent microalbuminuria within 20 years of onset of 
type1 diabetes (Hovind et al. 2004). There appear to be no substantial differences between patients 
with type2 and those with type1 with respect to the initiation, progression, and treatment of diabetic 
nephropathy (Parving 1998); however, the risk reductions seem proportional given the HbA1c 
differences 34% for albuminuria in The United Kingdom Prospective Diabetes Study (UKPDS) and 
54% in The Diabetes Control and Complications Trial Research (DCCT) (UKPDS33 1998). 
Microalbuminuria was said to confer a 60 to 85 percent risk of the development of overt proteinuria 
within 6 to 14 years (Bruce 2003). Without specific interventions, 20–40% of type2 diabetic patients 
with microalbuminuria progress to overt nephropathy (Al-Futaisi et al. 2006). The estimated risk of 
microalbuminuria is 3.41 cases per 100 patient-years at an HbA1c of 8%; 2.35 at an HbA1c of 7%; 
and 1.53 at an HbA1c of 6%. When compounded over a 9-year follow-up period, these hazard rates 
correspond to 26% cumulative incidence of patients developing microalbuminuria when held at an 
HbA1c of 8% over 9 years, versus 19% at an HbA1c of 7%, and 13% at an HbA1c of 6% (DCCT 
1996). Type1 patients whose intensive insulin therapy resulted in HbA1c levels 2% lower than those 
receiving conventional insulin therapies had a 54% lower incidence of nephropathy (Kronenberg et al. 
2008). In patients with type1 diabetes and overt proteinuria, aggressive blood pressure (BP) reduction 
reduced proteinuria by up to 50% (Kronenberg et al. 2008). A 10 mm Hg increase in mean arterial 
blood pressure, was one of the significant predictors for the development of persistent 
microalbuminuria (Hovind et al. 2004). In the UKPDS, a reduction in BP from 154 to 144 mm Hg 
was associated with a 30% reduction in microalbuminuria.  
A concise schema regarding the aforementioned process is illustrated in Figure 4.  
 
Figure 4. A schema regards to the process of making knowledge base 
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3.2 Authoring the Rules 
The next step is transferring all facts to the rules in CLIPS. To give a better perception about how the 
rules in the CLIPS knowledge base work, consider an example that is extracted from above fact list:  
“In type1 diabetes, each unit increase in HbA1c while 6 %< HbA1c=<10.1 %, adds 3% to chance of 
nephropathy; and for every one unit HbA1c less than 6%, the risk decrease by 3%.” 
This fact will be transferred to CLIPS rules (Figure 5) and will be tested by the data from four cases to 
demonstrate the results. (Figure 6) 
 
Figure 5. An example of a rule in CLIPS knowledge base 
 
Figure 6. Changing the risk of nephropathy in target cases after running CLIPS 
4 DISCUSSION AND CONCLUSION 
The developed knowledge-base model in this study confirmed that diabetes is regulated by various 
multiple factors which do not follow any simple model of inheritance; hence, risk advisor system 
could be of the most important methods of prediction and consequently prevention of its chronic 
complications heavy burden. 
There are several projects in Australia focusing on diabetes research. The Australian Diabetes obesity 
and lifestyle study (AusDiab) and Fremantle diabetes study are some examples that extensively focus 
on diabetes management. These studies focused on modifiable risks and their effects on diabetes 
outcome in general. In addition, there are some computerized information systems related to diabetes 




reminders for diabetes patients, a multimodal reasoning system for diabetic care (Montani et al. 2000), 
diabetic foot advisor (Awad & Tremaine 2000) etc. 
Currently, there is no decision support system for secondary prevention of diabetes that is based on a 
model focusing on relationships between diabetic modifiable risk factors and its complications 
individually. 
It can be seen that acquired knowledge in this model has been derived through an extensive literature 
review of epidemiological data in the domain; despite the fact that earlier expert systems in medicine 
cover narrow medical domains, or relying from expert opinions only (Spooner 2007). 
The decision support model of this study can be used to inform diabetic patients about the risk and 
severity of probable complications, help health advisors to convince patients to change their lifestyle, 
and to inform healthcare providers to design immediate preventive interventions before a patient loses 
her/his capability. 
The complete decision support model is heading for evaluation with real data of former studies on 
diabetes to determine prediction accuracy of the risk in different groups of patients and for each 
diabetic complication individually. Further work will be planned to integrate the system with existing 
patient databases, assess acceptance rate of the system by experts and updating the knowledge base of 
the model. 
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